Intellicell Biosciences, Inc. Embedded Derivative, Loss on Embedded Derivative
Intellicell Biosciences, Inc. reported Embedded Derivative, Loss on Embedded Derivative of -$6.27 million for the 9-month period ending 2012-09-30, per its 10-Q/A filed 2012-11-28.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:EmbeddedDerivativeLossOnEmbeddedDerivative · last filed 2012-11-28
- Intellicell Biosciences, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2012-09-30 was $7.52K.
| Period end | Embedded Derivative, Loss on Embedded Derivative 3 month | Embedded Derivative, Loss on Embedded Derivative 6 month | Embedded Derivative, Loss on Embedded Derivative 9 month |
|---|---|---|---|
| 2012-09-30 | $7.52K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-11-28 | -$6.27M 10-Q/A · filed 2012-11-28 | |
| 2012-06-30 | -$6.28M 10-Q/A · filed 2012-09-10 |